UCB SA, the Belgian maker of the allergy drug Zyrtec, agreed to buy Germany's Schwarz Pharma AG for 4.4 billion euros (US$5.6 billion) in cash and stock to gain medicines for Parkinson's disease, epilepsy and bladder control.
Shareholders of Schwarz will get 91.10 euros a share, Schwarz said in an e-mailed statement.
That's 20 percent more than the closing price on Friday. The Schwarz-Schuette family, which owns 60 percent of the drugmaker, backed the offer.
Schwarz is the third European family drugmaker to sell in less than a week as the cost of developing new products swells and older ones face generic competition. UCB will get three new drugs that may garner more than 2 billion euros a year in sales, including a patch for Parkinson's disease.
"Schwarz Pharma and UCB are direct competitors with a focus on diseases of the central nervous system," Alexander Groschke, head of equities research at Landesbank Rheinland-Pfalz, said in a note to clients. "Together they will be a world leader in neurology."
Schwarz, the first company to introduce a generic version of AstraZeneca Plc's ulcer drug Prilosec, is shifting from marketing medicines to developing its own products. Shareholders will get 50 euros a share in cash and 0.8735 UCB shares. Chief executive officer Patrick Schwarz-Schuette will get a seat on the board of the enlarged UCB.
UCB shares fell 1.99 euros, or 4.2 percent, to 45.05 euros at 9.04am in Brussels. Those of Schwarz climbed 11.3 euros, or 15 percent, to 87 euros.
UCB is relying on new medicines such as the epilepsy drug Keppra and Crohn's disease treatment Cimzia to spur growth.
Chief executive officer Roch Doliveux has helped focus the company with the purchase of UK biotechnology company Celltech Group Plc in 2004 and last year's sale of the chemicals unit.
"The management of UCB has already proven, through the acquisition of Celltech and other transactions, that it's in a position to successfully acquire and integrate a complementary business," Doliveux said in yesterday's statement.
The companies expect the transaction to generate annual cost savings of more than 300 million euros within three years.
The new company will have annual sales of more than 3.3 billion euros and a research and development budget of 770 million euros a year. UCB plans to sell new shares to help pay for the takeover.
The announcement comes just days after family holders of Serono SA, Europe's largest biotechnology company, agreed to sell their stake to Merck KGaA, controlled by the descendants of founder Friedrich Jacob Merck, in a deal valued at 10.6 billion euros.
Altana AG, controlled by the billionaire Quandt family, also agreed last week to sell its drug unit to Danish pharmaceuticals company Nycomed Holding AS for 4.5 billion euros.
Family shareholders are seeking consolidation as drugmakers grapple with the rising cost of developing new medicines and increasing competition from generics. Schwarz's shares had gained 41 percent in the year ended Sept. 22 amid speculation it could become a target as consolidation sweeps the German market.
NO HUMAN ERROR: After the incident, the Coast Guard Administration said it would obtain uncrewed aerial vehicles and vessels to boost its detection capacity Authorities would improve border control to prevent unlawful entry into Taiwan’s waters and safeguard national security, the Mainland Affairs Council (MAC) said yesterday after a Chinese man reached the nation’s coast on an inflatable boat, saying he “defected to freedom.” The man was found on a rubber boat when he was about to set foot on Taiwan at the estuary of Houkeng River (後坑溪) near Taiping Borough (太平) in New Taipei City’s Linkou District (林口), authorities said. The Coast Guard Administration’s (CGA) northern branch said it received a report at 6:30am yesterday morning from the New Taipei City Fire Department about a
IN BEIJING’S FAVOR: A China Coast Guard spokesperson said that the Chinese maritime police would continue to carry out law enforcement activities in waters it claims The Philippines withdrew its coast guard vessel from a South China Sea shoal that has recently been at the center of tensions with Beijing. BRP Teresa Magbanua “was compelled to return to port” from Sabina Shoal (Xianbin Shoal, 仙濱暗沙) due to bad weather, depleted supplies and the need to evacuate personnel requiring medical care, the Philippine Coast Guard (PCG) spokesman Jay Tarriela said yesterday in a post on X. The Philippine vessel “will be in tiptop shape to resume her mission” after it has been resupplied and repaired, Philippine Executive Secretary Lucas Bersamin, who heads the nation’s maritime council, said
REGIONAL STABILITY: Taipei thanked the Biden administration for authorizing its 16th sale of military goods and services to uphold Taiwan’s defense and safety The US Department of State has approved the sale of US$228 million of military goods and services to Taiwan, the US Department of Defense said on Monday. The state department “made a determination approving a possible Foreign Military Sale” to the Taipei Economic and Cultural Representative Office in the US for “return, repair and reshipment of spare parts and related equipment,” the defense department’s Defense Security Cooperation Agency said in a news release. Taiwan had requested the purchase of items and services which include the “return, repair and reshipment of classified and unclassified spare parts for aircraft and related equipment; US Government
More than 500 people on Saturday marched in New York in support of Taiwan’s entry to the UN, significantly more people than previous years. The march, coinciding with the ongoing 79th session of the UN General Assembly, comes close on the heels of growing international discourse regarding the meaning of UN Resolution 2758. Resolution 2758, adopted by the UN General Assembly in 1971, recognizes the People’s Republic of China (PRC) as the “only lawful representative of China.” It resulted in the Republic of China (ROC) losing its seat at the UN to the PRC. Taiwan has since been excluded from